PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.\', \'Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, Cleveland, OH, USA.\', \'Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.\', \'Section of Cardiovascular Research, Heart, Vascular and Thoracic Department, Cleveland Clinic Akron General, Akron, OH, USA.\', \'Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.\', \'Cardiovascular Division, Brigham and Women\'s Hospital, and Harvard Medical School, Boston, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/ehjcvp/pvaa138
?:doi
?:hasPublicationType
?:journal
  • European heart journal. Cardiovascular pharmacotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33337478
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33337478>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33337478>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all